Dr. Reddy's Announces the Launch of Over-the-Counter Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablets

Dr. Reddy's Laboratories RDY announced today that it has launched its over-the-counter Fexofenadine HCl and Pseudoephedrine HCl extended release tablets 180 /240 mg. The Food & Drug Administration approved Dr. Reddy's Abbreviated New Drug Application (ANDA) for Fexofenadine HCl and Pseudoephedrine HCl extended release tablets on June 22nd, 2011. Dr. Reddy's will market the product under store brand labels in the U.S. market. The product is a bioequivalent version of sanofi-aventis' Allegra® D24 Hour extended release tablets which received Rx-to-OTC switch approval from the FDA on January 24th, 2011.